Chick-fil-A Inc., an American restaurant chain specializing in chicken sandwiches, announced it will no longer serve chicken that is antibiotic-free. This decision reversed the brand's long-time pledge of "No Antibiotics Ever."
Why Chick-fil-A Changed Its Stance
According to Associated Press News, Chick-fil-A's move was prompted by the predicted supply shortage. This is also a sudden change of heart from its vow not to use chicken fed with antibiotics.
For years, Chick-fil-A has committed to serving only antibiotic-free chickens. The chain explained that this pledge is intended to help prevent human antibiotic resistance related to the widespread use of the drugs in most livestock production.
A Shift to Standard NAIHM
The restaurant announced it would now embrace a standard called the "no antibiotics important to human medicine" (NAIHM), which means it would allow some antibiotics. The NAIHM involves steering clear of certain medications that are commonly used for the treatment of humans and restricting the usage of animal antibiotics to particular instances of animal illness.
Chick-fil-A shared that it will apply the new NAIHM policy starting this spring. Through its spokesperson, the company said this move mirrors its concerns about its capability to obtain enough supplies of antibiotic-free chicken.
"To maintain supply of the high-quality chicken you expect from us, Chick-fil-A will shift from No Antibiotics Ever (NAE) to No Antibiotics Important To Human Medicine (NAIHM) starting in the Spring of 2024," Chick-fil-A said in a statement.
The fast-food chain added, "NAE means no antibiotics of any kind were used in raising the animal. NAIHM restricts the use of those antibiotics that are important to human medicine and commonly used to treat people, and allows the use of animal antibiotics only if the animal and those around it were to become sick."
Photo by: Malhar Patel/Unsplash


Ford to Move Some Lincoln Production From China to U.S. in 2030
OpenAI Executive Brad Lightcap to Leave for New AI Venture
Super Micro Stock Jumps 19% as AI Server Demand Drives Strong 2027 Outlook
ANZ Home Loan Applications Drop 12% After Australia Property Tax Changes
ASX Faces Legal Action Over Failed Blockchain CHESS Project
Samsung, SK Hynix Shares Surge on Report of Potential Temasek Investment
Paramount Weighs CNN Sale as $110B Warner Bros. Discovery Deal Faces Antitrust Fight
Maersk Raises 2026 Earnings Outlook as Shipping Profits Beat Expectations
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms
Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business
SMIC Shares Rally as Q2 Profit Surges 262% on Strong Chip Demand
Google Pushes Gemini AI Overhaul as Sergey Brin Targets Model Supremacy
Antofagasta Shares Drop 5% as Miner Cuts 2026 Copper Production Forecast
Lenovo Revenue Surges 43% as AI Demand Drives Record First-Quarter Growth
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan
Thyssenkrupp Raises 2026 Profit Outlook as Steel and Materials Units Strengthen 



